Status:
COMPLETED
Use of a Visual Pedagogy and Structure With Children With Autism for Routine Physical Exams
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Children's Hospital Colorado
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
4-10 years
Phase:
NA
Brief Summary
Children with autism spectrum disorders (ASDs) have unique social-communication and behavior impairments that complicate their medical management. This study aimed to evaluate the effectiveness of usi...
Detailed Description
Objective: This pilot study aimed to evaluate the effects of a picture-schedule reinforcement system on reducing problem behaviors in children with Autism Spectrum Disorder (ASD) during a physical exa...
Eligibility Criteria
Inclusion
- Chronological ages 4 to 10 years.
- Presumptive diagnosis of Autistic Disorder or Asperger's Disorder prior to study admission from a psychologist or psychiatrist experienced with children who have autism.
- Meets research criteria for Autistic Spectrum Disorder:
- Meets cut-off scores for autism spectrum on the Social Communication Questionnaire (SCQ) (cut-off = 15) and
- Meets empirically-derived algorithm cut-off scores for Autism Spectrum Disorders on the Autism Diagnostic Observation Schedule (ADOS).
- All subjects will have the ADOS administered by a clinician trained in research reliability standards.
- The Principal Investigator, a certified ADOS trainer and research reliable, or trained designee under the supervision of the Principal Investigator, will administer the ADOS.
- Participants will represent the typical DSM-IV diagnostic developmental profile of children on the autism spectrum and no neurological injuries or illnesses before the age of three years that could account for their symptoms (i.e., meningitis, encephalitis, severe head injury or seizure disorder).
- A Communication standard score ≤ 85, as measured by the Vineland Adaptive Behavior Scales - II.
- a) The VABS-II will be administered by the Principal Investigator or trained designee under the supervision of the Principal Investigator as part of the initial phone screening process.
- Children with an ASD, particularly school-aged children and adolescents, may present with myriad prescribed psychotropic medications. Therefore, we will not exclude children on a variety of psychotropic medications; rather we will conduct a qualitative analysis to look at this issue.
- No restrictions regarding race or gender will be applied to the autism or developmental disability sample. Every effort will be made not to over-represent any particular race and/or gender group.
- Physically healthy prior to physical exam.
- Previous exposure to visual systems. This will be assessed based on caregiver report during the phone screening using one question relating to the use of visual structure with the child.
- History of:
- Poor Cooperation
- Completely Uncooperative
- Physical exams rated by caregiver on 4-point scale of cooperation modified from Forsberg et al. \[56\].
- 0 = No problems with cooperation;
- 1 = Minor problems with cooperation: Child shows mild behavior problems and/or anxiety symptoms;
- 2 = Poor cooperation: Child's behavior problems and/or anxiety symptoms requires that the medical staff have to spend extra time and effort to manage the child and complete the exam;
- 3 = Completely uncooperative: Exam is not possible due to child's behavior problems and/or anxiety symptoms
Exclusion
- Participants with intelligence quotient standard scores \> 40.
- Presence of the following genetic or progressive neurological disorders known to be causative of or potentially resulting in a phenotype similar to autism:
- Fragile X,
- Landau Kleffner, Rett Disorder,
- Childhood Disintegrative Disorder, or
- Tuberous Sclerosis, based on screening by clinical staff and subsequent review by medical staff as needed
- Presence of vision or hearing loss or significant motor impairments.
- Wards of the State.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03232775
Start Date
September 1 2007
End Date
August 1 2011
Last Update
July 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.